NCT05769452

Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications

Effect of Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications in Pediatric Hematology and Oncology Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 214 (actual)
• Sponsor: Gülçin Özalp Gerçeker · Academic / Other
• Sex: All
• Age: 1 Year – 12 Years
• Healthy volunteers: Not accepted

Summary

Peripheral intravenous catheters (PIVCs) can be used frequently in pediatric hematology oncology patients. There are different types of PIVCs as open and closed. There are studies on adults using the closed IV catheter system, which is a type of PICK. However, no study was found in the literature in which the closed IV catheter system was used in the pediatric population.

Detailed description

The primary purpose of this research is; to evaluate the effect of two different catheter systems (closed IV catheter system: BD Nexiva™/ peripheral open IV catheter: BD Insyte™ Autoguard™) on catheter stay in pediatric hematology and oncology patients aged 1-12 years. The secondary aim of the research is; to evaluate the effect of two different catheter systems on the success of catheter placement and the development of complications in the first attempt in pediatric hematology and oncology patients.

Conditions

• Catheter Complications
• Catheter Leakage

Interventions

Type	Name	Description
DEVICE	closed IV catheter system (BD Nexiva™)	There is a high-pressure extension set and a Q-syte split septum needle-free intervention device at the tip of the catheter. It creates a closed integrated system with this apparatus, reducing the risk of catheter-related bloodstream infection.
DEVICE	open IV catheter (BD Insyte™ Autoguard™)	BD Instaflash™ needle technology improves initial entry success by confirming vascular access through the needle noch. It has flexible wings for secure cannula fixation.

Timeline

• Start date: 2022-04-01
• Primary completion: 2022-11-15
• Completion: 2022-11-30
• First posted: 2023-03-15
• Last updated: 2023-03-15

Locations

1 site across 1 country: Turkey (Türkiye)

Regulatory

• FDA-regulated device study